Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2021

01-06-2021 | Affective Disorder | Research article

The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran

Authors: Negar Jalali, Habibeh Taghavi Kojidi, Rahim Badrfam, Atefeh Zandifar

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Login to get access

Abstract

Purpose

Adherence to treatment is of great importance in patients with diabetes mellitus due to its necessity and benefits. The purpose of this study was to evaluate the relationship between personality disorder, depression and eating disorder with appropriate treatment acceptance and follow-up in patients with type 2 diabetes.

Methods

This cross-sectional study was performed in Imam Ali Medical Education Center in Karaj city of Alborz province of Iran. A total of 1320 patients were evaluated and were screened according to the inclusion criteria, including type 2 diabetes and those over 18 years of age. Finally, considering the exclusion criteria, 600 patients with type 2 diabetes were included in the study. Patients were divided into 4 groups. 150 patients with type 2 diabetes in the control group, 150 patients with type 2 diabetes with major depressive disorder, 150 patients with type 2 diabetes with personality disorder and 150 patients with type 2 diabetes and eating disorder were studied. Questionnaires used in the study included Hamilton Depression Rating Scale(HAM-D) for depression, Minnesota Multiphasic Personality Inventory II (MMPI II) questionnaire for personality disorders and Eating Disorder Diagnostic Scale(EDDS) for eating disorder. The Murisky questionnaire also assessed adherence to treatment in patients, which included 8 questions. Scores measure the degree of adherence to treatment.

Results

600 patients with type 2 diabetes were studied. Patients were divided into 4 groups (each group consisting of 150 patients) of control, depression, personality disorder and eating disorder. Mean age, sex, marital status and duration of diabetes were not significantly different in the study groups (P > 0.05). The mean Murisky score in patients with depression and personality disorder was significantly lower than the control group (P < 0.05) but the mean Murisky score in patients with eating disorder was not significantly different (P > 0.05). Patients with depression, paranoid, schizotypal, antisocial, borderline, avoidant and dependent personality disorder had less adherent to treatment than the control group.

Conclusions

Early psychiatric evaluation of patients with diabetes and identification of possible disorders can help improve diabetes control.
Literature
1.
go back to reference Navipour E, et al. Predict of risk factors associated with diabetes type 2 by using logistic regression. 2017;12(2):59–65. Navipour E, et al. Predict of risk factors associated with diabetes type 2 by using logistic regression. 2017;12(2):59–65.
2.
go back to reference Kayedi M, et al. The associaty of chlamydia pneumoniae, helicobacter pylori herpes simplex virus type 1 and Cytomegalovirus in the northern Persian gulf population. ISMJ. 2015;18(1):135–46. Kayedi M, et al. The associaty of chlamydia pneumoniae, helicobacter pylori herpes simplex virus type 1 and Cytomegalovirus in the northern Persian gulf population. ISMJ. 2015;18(1):135–46.
3.
go back to reference Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: IV. Diabetic macular edema. Ophthalmology. 1984;91(12):1464–74.CrossRef Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: IV. Diabetic macular edema. Ophthalmology. 1984;91(12):1464–74.CrossRef
4.
go back to reference Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRef Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRef
5.
go back to reference Amini M, Parvaresh E. Prevalence of macro-and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract. 2009;83(1):18–25.CrossRef Amini M, Parvaresh E. Prevalence of macro-and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract. 2009;83(1):18–25.CrossRef
6.
go back to reference Azizi Soleiman F, et al. The relationship between inflammation, oxidative stress, and metabolic risk factors in type 2 diabetic patients. Iranian J Diabetes Obesity. 2013;5(4):151–6. Azizi Soleiman F, et al. The relationship between inflammation, oxidative stress, and metabolic risk factors in type 2 diabetic patients. Iranian J Diabetes Obesity. 2013;5(4):151–6.
7.
go back to reference Klein HA, Lippa KD. Assuming control after system failure: type II diabetes self-management. Cogn Tech Work. 2012;14(3):243–51.CrossRef Klein HA, Lippa KD. Assuming control after system failure: type II diabetes self-management. Cogn Tech Work. 2012;14(3):243–51.CrossRef
8.
go back to reference Balducci S, Sacchetti M, Haxhi J, Orlando G, D'Errico V, Fallucca S, et al. Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2014;30(S1):13–23.CrossRef Balducci S, Sacchetti M, Haxhi J, Orlando G, D'Errico V, Fallucca S, et al. Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2014;30(S1):13–23.CrossRef
9.
go back to reference Kaholokula, J.K.A., et al., Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behavior Med, 2003. 26(5): p. 435–458. Kaholokula, J.K.A., et al., Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behavior Med, 2003. 26(5): p. 435–458.
10.
go back to reference Eskandari Khanghahi M, et al. Frequency of psychiatric and psychological disorders in patients with type II diabetes. J Mazandaran Univ Med Sci. 2017;27(155):37–45. Eskandari Khanghahi M, et al. Frequency of psychiatric and psychological disorders in patients with type II diabetes. J Mazandaran Univ Med Sci. 2017;27(155):37–45.
11.
go back to reference Jokela M, Elovainio M, Nyberg ST, Tabák AG, Hintsa T, Batty GD, et al. Personality and risk of diabetes in adults: pooled analysis of 5 cohort studies. Health Psychol. 2014;33(12):1618–21.CrossRef Jokela M, Elovainio M, Nyberg ST, Tabák AG, Hintsa T, Batty GD, et al. Personality and risk of diabetes in adults: pooled analysis of 5 cohort studies. Health Psychol. 2014;33(12):1618–21.CrossRef
12.
go back to reference Wisting L, et al. Adolescents with type 1 diabetes–the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One. 2015;10(11):e0141386. Wisting L, et al. Adolescents with type 1 diabetes–the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One. 2015;10(11):e0141386.
13.
go back to reference Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7(1):186.CrossRef Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7(1):186.CrossRef
14.
go back to reference Dunbar-Jacob J, Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54(12):S57–60.CrossRef Dunbar-Jacob J, Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54(12):S57–60.CrossRef
15.
go back to reference Chisholm-Burns MA, Spivey CA. The'cost'of medication nonadherence: consequences we cannot afford to accept. J Am Pharmacists Assoc. 2012;52(6):823–6.CrossRef Chisholm-Burns MA, Spivey CA. The'cost'of medication nonadherence: consequences we cannot afford to accept. J Am Pharmacists Assoc. 2012;52(6):823–6.CrossRef
16.
go back to reference Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. 2010;15(3):220–8.CrossRef Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. 2010;15(3):220–8.CrossRef
17.
go back to reference Williams JB. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45(8):742–7.CrossRef Williams JB. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45(8):742–7.CrossRef
18.
go back to reference Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.CrossRef Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.CrossRef
19.
go back to reference Ebrahimi A, et al. Reliability, validity, factor and discrimination power analysis of young mania rating scale among unipolar, bipolar depression and healthy people. 2017;16(3):333–344. Ebrahimi A, et al. Reliability, validity, factor and discrimination power analysis of young mania rating scale among unipolar, bipolar depression and healthy people. 2017;16(3):333–344.
21.
go back to reference Dehghani M, et al. Standardization and psychometric properties of Minnesota Multiphasic Personality Inventory (MMPI-2). J Psych. 2010;14(3):299–318. Dehghani M, et al. Standardization and psychometric properties of Minnesota Multiphasic Personality Inventory (MMPI-2). J Psych. 2010;14(3):299–318.
22.
go back to reference Stice E, Telch CF, Rizvi SL. Development and validation of the eating disorder diagnostic scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess. 2000;12(2):123–31.CrossRef Stice E, Telch CF, Rizvi SL. Development and validation of the eating disorder diagnostic scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess. 2000;12(2):123–31.CrossRef
23.
go back to reference Khabir L, Mohamadi N, Rahimi C. The validation of eating disorder diagnostic scale (EDDS). J Kermanshah Univ Med Sci. 2014;18(2):100–7. Khabir L, Mohamadi N, Rahimi C. The validation of eating disorder diagnostic scale (EDDS). J Kermanshah Univ Med Sci. 2014;18(2):100–7.
24.
go back to reference Morisky DE. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10:348–54.CrossRef Morisky DE. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10:348–54.CrossRef
25.
go back to reference Tan X, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). Innovations Pharm. 2014;5(3):5.CrossRef Tan X, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). Innovations Pharm. 2014;5(3):5.CrossRef
26.
go back to reference Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky-green test to evaluate medication adherence. Revista de saude publica. 2012;46(2):279–89.CrossRef Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky-green test to evaluate medication adherence. Revista de saude publica. 2012;46(2):279–89.CrossRef
27.
go back to reference Al-Qazaz HK, et al. The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–21.CrossRef Al-Qazaz HK, et al. The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–21.CrossRef
28.
go back to reference Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Global J Health Sci. 2015;7(4):173–83.CrossRef Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Global J Health Sci. 2015;7(4):173–83.CrossRef
29.
go back to reference Zhang J, et al. Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s republic of China. Neuropsychiatr Dis Treat. 2013;9:1289.PubMed Zhang J, et al. Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s republic of China. Neuropsychiatr Dis Treat. 2013;9:1289.PubMed
30.
go back to reference Zhang Y, Ting RZW, Yang W, Jia W, Li W, Ji L, et al. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence: 中国人 2 型糖尿病抑郁情况及其与高血糖, 低血糖及治疗依从性关系的研究. J Diabetes. 2015;7(6):800–8.CrossRef Zhang Y, Ting RZW, Yang W, Jia W, Li W, Ji L, et al. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence: 中国人 2 型糖尿病抑郁情况及其与高血糖, 低血糖及治疗依从性关系的研究. J Diabetes. 2015;7(6):800–8.CrossRef
31.
go back to reference Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–403.CrossRef Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–403.CrossRef
32.
go back to reference Niraula K, Kohrt BA, Flora MS, Thapa N, Mumu SJ, Pathak R, et al. Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. BMC Psychiatry. 2013;13(1):309.CrossRef Niraula K, Kohrt BA, Flora MS, Thapa N, Mumu SJ, Pathak R, et al. Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. BMC Psychiatry. 2013;13(1):309.CrossRef
33.
go back to reference Egede LE, Dismuke CE. Serious psychological distress and diabetes: a review of the literature. Current Psychiatry Reports. 2012;14(1):15–22.CrossRef Egede LE, Dismuke CE. Serious psychological distress and diabetes: a review of the literature. Current Psychiatry Reports. 2012;14(1):15–22.CrossRef
34.
go back to reference Kilbourne AM, Reynolds CF III, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13(3):202–10.CrossRef Kilbourne AM, Reynolds CF III, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13(3):202–10.CrossRef
35.
go back to reference Maeda U, Shen BJ, Schwarz ER, Farrell KA, Mallon S. Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behavior Med. 2013;20(1):88–96.CrossRef Maeda U, Shen BJ, Schwarz ER, Farrell KA, Mallon S. Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behavior Med. 2013;20(1):88–96.CrossRef
37.
go back to reference Pollock-BarZiv SM, Davis C. Personality factors and disordered eating in young women with type 1 diabetes mellitus. Psychosomatics. 2005;46(1):11–8.CrossRef Pollock-BarZiv SM, Davis C. Personality factors and disordered eating in young women with type 1 diabetes mellitus. Psychosomatics. 2005;46(1):11–8.CrossRef
38.
go back to reference Kruisdijk F, Hopman-Rock M, Beekman ATF, Hendriksen IJM. Personality traits as predictors of exercise treatment adherence in major depressive disorder: lessons from a randomised clinical trial. Int J Psychiatry Clin Pract. 2020;24(4):380–6.CrossRef Kruisdijk F, Hopman-Rock M, Beekman ATF, Hendriksen IJM. Personality traits as predictors of exercise treatment adherence in major depressive disorder: lessons from a randomised clinical trial. Int J Psychiatry Clin Pract. 2020;24(4):380–6.CrossRef
39.
go back to reference Nieto-Martínez R, González-Rivas JP, Medina-Inojosa JR, Florez H. Are eating disorders risk factors for type 2 diabetes? A systematic review and meta-analysis. Current Diabetes Reports. 2017;17(12):138.CrossRef Nieto-Martínez R, González-Rivas JP, Medina-Inojosa JR, Florez H. Are eating disorders risk factors for type 2 diabetes? A systematic review and meta-analysis. Current Diabetes Reports. 2017;17(12):138.CrossRef
40.
go back to reference Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.CrossRef Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.CrossRef
41.
go back to reference Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010;87(3):302–12.CrossRef Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010;87(3):302–12.CrossRef
Metadata
Title
The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran
Authors
Negar Jalali
Habibeh Taghavi Kojidi
Rahim Badrfam
Atefeh Zandifar
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00722-x

Other articles of this Issue 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Go to the issue